198 related articles for article (PubMed ID: 26944058)
1. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
[TBL] [Abstract][Full Text] [Related]
2. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.
Chang Y; Wu Q; Tian T; Li L; Guo X; Feng Z; Zhou J; Zhang L; Zhou S; Feng G; Han F; Yang J; Huang F
Tumour Biol; 2015 Aug; 36(8):6083-93. PubMed ID: 25833691
[TBL] [Abstract][Full Text] [Related]
3. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.
Basile JR; Gavard J; Gutkind JS
J Biol Chem; 2007 Nov; 282(48):34888-95. PubMed ID: 17855350
[TBL] [Abstract][Full Text] [Related]
4. Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells.
Yang YH; Zhou H; Binmadi NO; Proia P; Basile JR
PLoS One; 2011; 6(10):e25826. PubMed ID: 22028792
[TBL] [Abstract][Full Text] [Related]
5. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway.
Basile JR; Afkhami T; Gutkind JS
Mol Cell Biol; 2005 Aug; 25(16):6889-98. PubMed ID: 16055703
[TBL] [Abstract][Full Text] [Related]
7. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
Sun T; Krishnan R; Swiercz JM
J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
[TBL] [Abstract][Full Text] [Related]
8. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
9. Plexin-B1: a potential diagnostic biomarker for glioma and a future target for glioma immunotherapy.
Zhang Y; Li Q; Zhuang R; Gao Z; Liu J; Li J; Yang A; Cheng G; Jin B
J Neuroimmunol; 2012 Nov; 252(1-2):113-7. PubMed ID: 22939532
[TBL] [Abstract][Full Text] [Related]
10. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
[TBL] [Abstract][Full Text] [Related]
11. Plexin-B2 promotes invasive growth of malignant glioma.
Le AP; Huang Y; Pingle SC; Kesari S; Wang H; Yong RL; Zou H; Friedel RH
Oncotarget; 2015 Mar; 6(9):7293-304. PubMed ID: 25762646
[TBL] [Abstract][Full Text] [Related]
12. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG.
Aurandt J; Vikis HG; Gutkind JS; Ahn N; Guan KL
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12085-90. PubMed ID: 12196628
[TBL] [Abstract][Full Text] [Related]
13. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.
Swiercz JM; Kuner R; Offermanns S
J Cell Biol; 2004 Jun; 165(6):869-80. PubMed ID: 15210733
[TBL] [Abstract][Full Text] [Related]
14. Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
Nalabothula N; Lakka SS; Dinh DH; Gujrati M; Olivero WC; Rao JS
Int J Oncol; 2007 Mar; 30(3):669-78. PubMed ID: 17273768
[TBL] [Abstract][Full Text] [Related]
15. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.
Jacob L; Sawma P; Garnier N; Meyer LA; Fritz J; Hussenet T; Spenlé C; Goetz J; Vermot J; Fernandez A; Baumlin N; Aci-Sèche S; Orend G; Roussel G; Crémel G; Genest M; Hubert P; Bagnard D
Oncotarget; 2016 Sep; 7(36):57851-57865. PubMed ID: 27506939
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of plexins signaling in glioma progression and therapy.
Angelopoulou E; Piperi C
Cancer Lett; 2018 Feb; 414():81-87. PubMed ID: 29133239
[TBL] [Abstract][Full Text] [Related]
18. Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner.
Binmadi NO; Yang YH; Zhou H; Proia P; Lin YL; Batista De Paula AM; Sena Guimarães AL; Poswar FO; Sundararajan D; Basile JR
Am J Pathol; 2012 Mar; 180(3):1232-1242. PubMed ID: 22252234
[TBL] [Abstract][Full Text] [Related]
19. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.
Qiang R; Wang F; Shi LY; Liu M; Chen S; Wan HY; Li YX; Li X; Gao SY; Sun BC; Tang H
Int J Biochem Cell Biol; 2011 Apr; 43(4):632-41. PubMed ID: 21216304
[TBL] [Abstract][Full Text] [Related]
20. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
